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Abstract
Background: Data on complementary and alternative medicine (CAM) use in patients with cardiovascular disease
(CVD) are lacking. We aim to investigate the prevalence of CAM use among patients with CVD attending a tertiary
centre for cardiovascular care, their attitudes and beliefs towards CAM, and factors associated with CAM usage.
Methods: A cross-sectional, self-administered written survey was conducted on consecutive patients attending
outpatient cardiovascular clinics at our tertiary institution over 2 months from June to July 2014. Information
gathered included demographic data and various aspects of CAM use.
Results: A total of 768 responses (562 males, mean age 57 ± 13 years, 74 % Chinese, 6 % Malay, 14 % Indian) were
included. The prevalence of CAM use in the cohort was 43.4 % (333/768). Biologically-based systems (29.4 %) was
the most common type of CAM used. Some patients (19.0 %) used multiple types of CAM simultaneously. External
influences (78.1 %) were cited more than internal influences (47.8 %) to affect CAM use. Malay ethnicity (compared
to Chinese) was the only significant negative multivariate predictor of CAM use (OR = 0.531 (95 % CI 0.147 to 0.838),
p = 0.018). A significantly higher proportion of CAM users compared to non-CAM users were non-compliant to
medications (35.6 %, n = 114 vs. 20.5 %, n = 84, p < 0.001) and consults (41.4 %, n = 130 vs. 28.1 %, n = 112, p < 0.001)
respectively.
Conclusion: The usage of CAM is prevalent amongst our patients with CVD. CAM use was associated with poorer
reported compliance to medications and consults. Understanding the factors influencing CAM use amongst CVD
patients provides medical professionals with an opportunity to better discuss CAM use and potentially enhance the
patient-physician interaction.
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Background
Complementary and alternative medicine (CAM) is
commonly used for treatment of cardiovascular diseases
(CVD) in many countries [1, 2]. CAM is defined as a
group of diverse medical and healthcare systems, prac-
tices and products that are not presently considered to
be part of conventional medicine [3]. Studies conducted
in Western countries report as much as 65 % of the
study population using some form of CAM [4–6]. In
Singapore, CAM use amongst patients is prevalent [7, 8].
Past studies have evaluated CAM use in local cancer
patients [8–10], diabetes [11] and epilepsy [12], but data
in patients with CVD are lacking.
The usage of CAM could have potential implications
for patients and doctors. Poor communication between
patients and doctors regarding CAM use has been re-
ported overseas [13, 14] and locally [7]. Patients were
unaware of potential health risks of CAM [15], including
drug interactions, side effects and non-compliance to
conventional medicine [16]. This is especially important
in patients with CVD, who may consume medications
with narrow therapeutic index and extensive drug inter-
action profiles [17]. In addition, non-compliance to
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medications and visits have been shown to be a strong
predictor of adverse outcomes in CVD patients [18–20].
As such, the use of CAM could result in poor patient
outcomes [21] given that the potential benefits of CAM
in CVD in general are not well established [22].
In this study, we aim to investigate the prevalence of
CAM use among patients with CVD (including coronary
artery disease, cardiac failure, stroke) attending a tertiary
centre for cardiovascular care, their attitudes and beliefs
towards CAM use, as well as factors associated with
CAM usage.
Methods
A cross-sectional, self-administered written survey was
conducted on consecutive patients attending outpatient
cardiovascular clinics at our tertiary institution over a
period of 2 months from June to July 2014. Approval for
the study was obtained from the SingHealth Centralised
Institutional Review Board.
The questionnaire, available in English and Chinese,
was developed based on similar topics used in previous
studies [10, 15], and adapted to a local context. The
questionnaire was pilot tested among twenty patients
with similar profiles to our target population and further
refined to ensure that all the questions were easily
understood and interpreted uniformly based on feedback
from the pilot. Responses were recorded using a 4 point
Likert scale. Clinical information from the questionnaire
was supplemented from patients’ hospital medical re-
cords. These included clinical characteristics and risk
factors (eg. diabetes mellitus, hypertension, hyperlipid-
emia), physical examination findings (eg. Body mass
index, systolic blood pressure and diastolic blood pres-
sure), laboratory test results (eg. HbA1c, LDL) and med-
ications. The presence of risk factors like diabetes,
mellitus, hypertension and hyperlipidemia was based on
the self-reported questionnaire and/or documentation of
such a clinical condition from the records.
In the questionnaire, the term “non-western medicine”
was used in lieu of CAM as it facilitated better under-
standing of the term in our local context based on data
from the pilot study. As seen from question 17 of the
questionnaire (see Additional file 1), the components are
similar. We classified types of CAM into 4 main groups
[3] namely (1) biologically-based systems (eg. Traditional
Chinese Medicine (TCM), Jamu (Malay traditional medi-
cine), herbs, vitamins), (2) manipulative and body-based
methods (eg. massage, acupuncture, chiropractice), (3)
mind-body interventions (eg. relaxation therapies like
yoga and meditation, tai chi, chi gong) and (4) energy
therapies (eg. magnetic therapy). CAM that were not
specified by the participants were classified under (5)
others. The data was analysed based on this grouping.
Questions to ascertain the physician’s role in the patient’s
use of CAM, self-reported compliance to conventional
medicine, follow-up appointments and trust for doctors
were also included. A sample of the questionnaire is in-
cluded in the Additional file 1.
Statistical analysis
Statistical analysis was performed using Statistical Package
for the Social Sciences (SPSS) 22.0 for Windows (SPSS
Inc, Chicago, IL). The demographic and risk factor profile
of the study population was characterized using descrip-
tive statistics. Comparison between the two groups (CAM
users vs CAM non-users) was performed using Student’s
t-test for parametric data, Mann-Whitney U test for non-
parametric data and Chi-squared test for categorical data.
The relationship between CAM usage and other factors
was explored using bivariate correlational analyses and
multivariate linear regression models.
Results
The initial response rate was 71.1 % (1000 out of 1406
patients). Of the 1000 patients which responded, 768
had complete responses (562 males, mean age 57 ±
13 years, 74 % Chinese, 6 % Malay, 14 % Indian), the
remaining were excluded due to incompleteness of re-
sponse. See Table 1.
The prevalence of CAM use in the cohort was 43.4 %
(333/768). Types of CAM use included biologically-based
systems (29.4 %), manipulative/body based therapies
(22.3 %), mind-body systems (11.3 %), energy therapies
(1.2 %) and others (5.1 %). Some patients (19.0 %) used
more than one type of CAM simultaneously. Among CAM
users, concomitant usage of prescribed medications are as
follows; beta-blockers (41.1 %), aspirin (37.5 %), angiotensin
converting enzyme (ACE) inhibitors and/or angiotensin re-
ceptor blockers (ARB) (33.6 %), calcium channel blockers
(26.1 %), clopidogrel (18.3 %), oral hypoglycemic agents
(15.3 %), warfarin (1.8 %) and digoxin (1.8 %).
Since a significant proportion of CAM users (146/333)
use more than one type of CAM, we compared patient
characteristics between CAM users that use more than
one type of CAM and CAM users that only use a certain
type of CAM strictly, for which the top three analysed
were biologically-based systems (27.3 %), manipulative/
body based therapies (13.2 %) and mind-body systems
(3.3 %). See Table 2.
Reasons for using CAM was classified into external in-
fluences (78.1 %), internal influences (47.8 %) and others
(6.6 %). External influences come from friends and fam-
ily (62.5 %), recommendation from the doctor (20.1 %)
and media (8.4 %). Internal influences included perceiv-
ing CAM as having less side effects (36.3 %), better effi-
cacy of CAM (10.2 %), lower cost of CAM (7.5 %), and
poor results from conventional western medicine
(6.6 %). (Table 3) Malay ethnicity (as compared to the
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Table 1 Demographics of the study population
Overall (n = 768) CAM user (n = 333) CAM non-user (n = 435) P-valuea
Demographics
Age 56.8 (12.6) 56.8 (10.9) 56.7 (13.7) 0.963
Gender 0.442
Male 562 (73.2 %) 239 (71.8 %) 323 (74.3 %)
Female 206 (26.8 %) 94 (28.2 %) 112 (25.7 %)
Ethnicity 0.010
Chinese 569 (74.1 %) 264 (79.3 %) 305 (70.1 %)
Malay 43 (5.6 %) 10 (3.0 %) 33 (7.6 %)
Indian 107 (13.9 %) 39 (11.7 %) 68 (15.6 %)
Others 49 (6.4 %) 20 (6.0 %) 29 (6.7 %)
Education 0.485
≤ Secondary/ITE 243 (32.1 %) 112 (34.1 %) 131 (30.5 %)
Polytechnic diploma/A Level 235 (31.0 %) 102 (31.1 %) 133 (31.0 %)
Degree/Post-graduate 279 (36.9 %) 114 (34.8 %) 165 (38.5 %)
Occupation 0.750
White collar 315 (51.6 %) 134 (53.4 %) 181 (50.4 %)
Blue collar 101 (16.6 %) 41 (16.3 %) 60 (16.7 %)
Unemployed/homemaker 194 (31.8 %) 76 (30.3 %) 118 (32.9 %)
Housing 0.672
≤ 3 room public apartment 74 (10.4 %) 35 (11.5 %) 39 (9.6 %)
4-5 room public apartment 350 (49.2 %) 146 (47.9 %) 204 (50.2 %)
Private property 287 (40.4 %) 124 (40.7 %) 163 (40.1 %)
Smoking 0.112
No 522 (71.7 %) 217 (68.7 %) 305 (74.0 %)
Ever smoker 206 (28.3 %) 99 (31.3 %) 107 (26.0 %)
Alcohol 0.933
No 337 (46.0 %) 144 (45.9 %) 193 (46.2 %)
Ever drinker 395 (54.0 %) 170 (54.1 %) 225 (53.8 %)
Clinical Characteristics
BMI 25.7 (5.2) 25.7 (5.3) 25.7 (5.2) 0.899
Systolic Blood Pressure 131.4 (17.6) 132.2 (18.2) 130.8 (17.2) 0.284
Diastolic Blood Pressure 70.9 (9.8) 71.4 (10.0) 70.4 (9.7) 0.157
Diabetes mellitus 168 (21.9 %) 69 (20.7 %) 99 (22.8 %) 0.498
Hypertension 374 (48.7 %) 165 (49.5 %) 209 (48.0 %) 0.680
Hyperlipidemia 489 (61.4 %) 214 (64.3 %) 275 (63.2 %) 0.765
HbA1C (%)b 6.3 (1.4) 6.3 (1.4) 6.4 (1.3) 0.588
LDL Cholesterol (mmol/L)c 2.7 (1.0) 2.7 (1.0) 2.7 (1.0) 0.488
Abbreviations and definitions
ITE Institute of Technical Education. HbA1C Glycated hemoglobin, White collar workers perform job duties in an office setting, Blue collar workers perform labour
jobs or work with their hands, Public apartment refers to heavily subsidized housing built by the government. Families with gross monthly income in excess of
$10,000 are not eligible to directly purchase these subsidized apartments from the Housing and Development Board
Mean and SD are reported for continuous data and frequency and percentages for categorical data
aComparing CAM users and CAM non-users
bHbA1C – 473 patients with missing data
cLDL – 303 patients with missing data
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Chinese) was the only significant negative multivariate
predictor of CAM use (OR = 0.531 (95 % CI 0.147 to
0.838), p = 0.018) (Table 4).
Approximately half of patients (50.8 %, n = 169) found
CAM effective in treating their heart condition, while a
smaller proportion (25.2 %, n = 84) found CAM more
Table 2 Patient characteristics based on types of CAM use
Biologically-based
systems (n = 91)
Manipulative and body-based
methods (n = 44)
Mind-body interventions
(n = 11)
More than 1 type of CAM
used (n = 146)
P-valuea
Demographics
Age 57.3 (9.7) 57.6 (11.8) 57.2 (11.0) 56.6 (11.0) 0.867
Gender 0.262
Male 68 (74.7 %) 36 (81.8 %) 7 (63.6 %) 98 (67.1 %)
Female 23 (25.3 %) 8 (18.2 %) 4 (36.4 %) 48 (32.9 %)
Ethnicity 0.026
Chinese 72 (79.1 %) 35 (79.5 %) 6 (54.5 %) 118 (80.8 %)
Malay 3 (3.3 %) 2 (4.5 %) 0 (0.0 %) 4 (2.7 %)
Indian 8 (8.8 %) 2 (4.5 %) 4 (36.4 %) 20 (13.7 %)
Others 8 (8.8 %) 5 (11.4 %) 1 (9.1 %) 4 (2.7 %)
Education 0.136
≤ Secondary/ITE 38 (42.7 %) 15 (34.1 %) 0 (0.0 %) 39 (27.1 %)
Polytechnic diploma/A Level 24 (27.0 %) 15 (34.1 %) 4 (40.0 %) 51 (35.4 %)
Degree/Post-graduate 27 (30.3 %) 14 (31.8 %) 6 (60.0 %) 54 (37.5 %)
Occupation 0.751
White collar 37 (54.4 %) 16 (47.1 %) 4 (80.0 %) 62 (55.4 %)
Blue collar 11 (16.2 %) 8 (23.5 %) 0 (0.0 %) 14 (12.5 %)
Unemployed/homemaker 20 (29.4 %) 10 (29.4 %) 1 (20.0 %) 36 (32.1 %)
Housing 0.880
≤ 3 room public apartment 8 (9.6 %) 4 (10.0 %) 0 (0.0 %) 17 (12.7 %)
4–5 room public apartment 40 (48.2 %) 22 (55.0 %) 4 (40.0 %) 63 (47.0 %)
Private property 35 (42.2 %) 14 (35.0 %) 6 (60.0 %) 54 (40.3 %)
Smoking 0.647
No 57 (67.1 %) 27 (64.3 %) 8 (72.7 %) 99 (72.3 %)
Ever smoker 28 (32.9 %) 15 (35.7 %) 3 (27.3 %) 38 (27.7 %)
Alcohol 0.709
No 35 (41.7 %) 15 (38.5 %) 6 (54.5 %) 68 (47.9 %)
Ever drinker 49 (58.3 %) 24 (61.5 %) 5 (45.5 %) 74 (52.1 %)
Clinical Characteristics
BMI 25.5 (5.6) 26.3 (5.1) 24.3 (2.3) 25.8 (5.3) 0.906
Systolic Blood Pressure 130.4 (20.1) 134.0 (17.0) 122.1 (17.1) 132.3 (17.6) 0.484
Diastolic Blood Pressure 69.8 (9.5) 73.7 (11.3) 69.1 (10.2) 71.2 (9.9) 0.606
Diabetes mellitus 30 (33.0 %) 9 (20.5 %) 1 (9.1 %) 27 (18.5 %) 0.068
Hypertension 39 (42.9 %) 27 (61.4 %) 2 (18.2 %) 77 (52.7 %) 0.057
Hyperlipidemia 55 (60.4 %) 28 (63.6 %) 6 (54.5 %) 99 (67.8 %) 0.749
HbA1C (%)b 6.7 (2.0) 6.1 (0.8) 5.6 (0.2) 6.2 (1.3) 0.279
LDL Cholesterol (mmol/L)c 2.7 (1.0) 2.6 (1.0) 2.4 (0.6) 2.7 (0.9) 0.950
Energy therapies not included in analysis as only one patient used energy therapy only
Mean and SD are reported for continuous data and frequency and percentages for categorical data
aComparing one type of CAM use only (excluding energy therapies and others) and more than one type of CAM use
bHbA1C – 473 patients with missing data
cLDL – 303 patients with missing data
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effective than conventional western medicine in treating
their heart condition. Perceived effectiveness was highest
in patients who used biologically based systems (31.5 %)
and lowest in energy therapies (1.2 %). A small number
of CAM users (7.8 %, n = 26) experienced side effects
from CAM which included gastrointestinal complaints,
general malaise, allergy and rash.
A significantly higher proportion of CAM users
compared to non-CAM users (35.6 %, n = 114 vs.
20.5 %, n = 84, p < 0.001) were non-compliant (forgot
to take medicines occasionally or most of the time) to
medications. More CAM users reported non-compliance
to doctor visits compared to non-CAM users (41.4 %, n =
130 vs. 28.1 %, n = 112, p < 0.001). Most patients reported
that their doctors did not ask them about their usage of
CAM (60.5 %, n = 465). Among CAM users, only 66
(19.8 %) asked their doctors about their CAM usage; rea-
sons include – their doctor did not ask them first (37.2 %,
n = 124), lack of time during the consult (11.4 %, n = 38),
doctor would disapprove (8.4 %, n = 28) and doctor would
not understand (5.4 %, n = 18). A sizable proportion
(72.8 %, n = 559) would like to know more about CAM
from their doctors.
Discussion
The use of CAM in CVD patients in Western coun-
tries is prevalent ranging from 36–64 % [15, 23–25].
In Singapore, there is a lack of data on CAM use in
CVD patients. However, in cancer patients, the use of
CAM was found to be at least half at about 55–56 %
[8, 9]. In our cohort, we found similar rates of CAM
use at about 43.4 %.
Out of the total CAM users, a significant number
(43.8 %) use more than one type of CAM. This is similar
to western studies of CAM use in CVD patients [23, 25],
but not well studied in Singapore. This could be due
to the variability between studies in grouping types of
CAM. The use of multiple CAM is significant as it
increases the probability of adverse medication side
effects [22].
Understanding the factors that influence a patient to
use CAM is important in helping the physician discuss
such therapies with the patient. External influences
(78.1 %) form the greatest “push factor” for CAM use, of
which friends and family (62.5 %) was most common
reason cited for its use. This is congruent with other
studies done in Singapore [7, 9, 12, 26]. A survey of 704
CAM users in Singapore listed recommendation by
friends and family (70.6 %) as the top reason for their
CAM use [26]. Family tradition was found to be an im-
portant reason for the usage of CAM in a general study
of CAM use in Singapore [7]. Another Singapore study
of cancer patients found that friends, other cancer pa-
tients and family were their main source of information
of CAM [9]. In contrast, in Western cohorts, internal in-
fluences, namely adverse drug reactions of conventional
therapy [27], perceived proven benefit of CAM [24, 28]
and few side effects of CAM [24, 28] were the main
drivers for CAM use [29]. This could be due to Asian
cultural differences, in which opinions of the family are
greatly valued in the choice of medical treatment [30].
Studies using Western populations have found CAM
users to be more likely female, middle aged, affluent and
well-educated [4, 31]. In our study, these factors were
Table 3 Reasons for CAM usage
CAM users (n = 333)
External influences 260 (78.1 %)
Family/friends recommendation 208 (62.5 %)
Doctor’s recommendation 67 (20.1 %)
Media influence 28 (8.4 %)
Internal influences 159 (47.8 %)
Poor results from Western medicine 22 (6.6 %)
CAM is cheaper 25 (7.5 %)
CAM works better 34 (10.2 %)
CAM has less side effects 21 (36.3 %)
Others 22 (6.6 %)
Percentages are reported for categorical data
Table 4 Multivariate predictors of CAM use
Prevalence
ratio




Male 0.880 0.597 to 1.299 0.521
Ethnicity
Others 0.622 0.305 to 1.267 0.191
Indian 0.851 0.510 to 1.421 0.537
Malay 0.351 0.147 to 0.838 0.018
Chinese*
Age 0.995 0.979 to 1.011 0.535
Education
Diploma/A Level 0.974 0.625 to 1.518 0.909
Degree/Postgraduate 0.678 0.426 to 1.079 0.101
< Secondary school/ITE*
Occupation
Blue collar 1.157 0.654 to 2.047 0.616
White collar 1.218 0.787 to 1.884 0.376
Retired/unemployed*
Housing
≤ 3 room public flat 0.979 0.517 to 1.852 0.947
4–5 room public flat 0.835 0.561 to 1.243 0.375
Private Property*
*Reference group
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not found to be associated with CAM use, highlighting
the possible effect of cultural and environmental differ-
ences. In our study, Malay ethnicity was significantly
associated with less CAM use than Chinese in CVD pa-
tients. In several Singapore studies on general CAM
users [7], cancer patients [8, 9] and epilepsy [12], Chinese
ethnicity was found to be associated with CAM use. A
possible explanation is the prevalent use of TCMs for the
treatment of CVD risk factors (eg. HTN and DM) and
cardiovascular diseases in the Chinese [32].
In patients with CVD, compliance to conventional
western medicine may be affected by CAM use. In a
study of hypertensive medication adherence, females
CAM users were found to have lower compliance than
those who did not use CAM [33]. Our study also
showed that CAM users were less compliant to conven-
tional medicine as well as follow up appointments com-
pared to non-CAM users. This has strong implications
in the management of patients. Non-compliance to med-
ications and visits has been shown to be a strong pre-
dictor of adverse outcomes in CVD patients [18–20].
Addressing a patient’s concerns and expectations about
both CAM and the conventional medications may help
improve such compliance. In our study, we found that
the prevalence of CAM disclosure to physicians is gener-
ally low. Similarly, a study done in Singapore showed
that 74 % of CAM users did not discuss their use with
doctors [7]. This is also shown in a study of caregivers of
a paediatric epilepsy population [12]. In that study, up to
80 % of caregivers did not inform their doctors about
CAM use because they were not asked to. Western stud-
ies also made similar observations for CAM users in
general [34] and for CVD [15, 23, 29]. The most cited
reason for non-disclosure in our study is that the doc-
tors did not ask them about their usage of CAM
(60.5 %). Reasons such as perceived disapproval from
doctors [29, 35] and insufficient consult time featured
less commonly. This is in line with other studies that
also identified the lack of physician input as an import-
ant factor [17, 29]. A study [10] on CAM use in cancer
patients identified that healthcare professionals perceive
themselves to have inadequate knowledge (58.8 %) or
were not up to date with the best evidence on CAM use
(79.2 %) in oncology. This lack of knowledge may be one
of the reasons behind a physicians’ avoidance of raising
the CAM issue with patients. This issue has also been
highlighted in a study of CAM use in paediatric epilepsy
caregivers [12], whereby majority of the healthcare pro-
viders did not comment on CAM use when asked by
patients. Of note, 72.8 % of our sample cohort was keen
to know more about CAM from their doctors. This
highlights the role of doctors in providing such informa-
tion and recommendations about CAM [7]. An open
physician-patient setting whereby such issues of CAM
can be readily discussed could help improve the thera-
peutic relationship and potentially improve compliance
and possibly outcomes [36].
Limitations
The study population was from the outpatient cardiovas-
cular clinics at a single tertiary cardiac centre and might
not be representative of the general population of patients
with CVD. Males were over-represented (73.2 %) in our
study, possibly reflecting their higher CVD burden [37].
The impact of CAM usage on CVD outcomes was not
assessed in this cross-sectional survey, however the results
raise interesting questions for future work.
Conclusion
The usage of CAM is prevalent amongst our patients with
CVD. The use of CAM was associated with poorer re-
ported compliance to medications and consults. Under-
standing the factors influencing CAM use amongst CVD
patients provides medical professionals with an opportun-
ity to better discuss CAM use and potentially enhance the
patient-physician interaction.
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